While we had noticed insufficient recombination of the Smarca5 locus in a subset of tumor cells at early stages (Fig. 2e), we found that the fraction of SMARCA5-negative cells decreased during postnatal tumor development (Fig. 2i). The gene discussed is SMARCA5; the disease is neoplasm.